We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 25, 2020

First-Line Treatment of Double- and Triple-Hit Lymphomas

American Journal of Hematology


Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Hematology
First-Line Treatment of Double- and Triple-Hit Lymphomas: Survival and Tolerance Data From a Retrospective Multicenter French Study
Am. J. Hematol 2020 Dec 11;[EPub Ahead of Print], MC Laude, L Lebras, P Sesques, H Ghesquieres, S Favre, K Bouabdallah, C Croizier, R Guieze, LD La Rochelle, E Gyan, R Chin, T Aurran-Schleinitz, A Marouf, B Deau-Fischer, P Coppo, S Malot, X Roussel, A Chauchet, M Schwarz, C Bescond, T Lamy de la Chapelle, L Bussot, S Carras, B Burlet, C Rossi, A Daniel, F Morschhauser, F Subtil, AS Michallet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading